Evidence map›Paper›PMID 32809187›Full record

ArticleExperimental & applied acarology2020

Inventory of Varroa destructor susceptibility to amitraz and tau-fluvalinate in France.

Gabrielle Almecija, Benjamin Poirot, Précillia Cochard, Christelle Suppo

Abstract read
PubMed Publisher
In one paragraph

Article in Experimental & applied acarology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Gabrielle AlmecijaAPINOV, Research and Training Center, 10 rue Henri Bessemer, 17140, Lagord, France. gabrielle.almecija@apinov.com.ORCID http://orcid.org/0000-0002-5850-0767
Benjamin PoirotAPINOV, Research and Training Center, 10 rue Henri Bessemer, 17140, Lagord, France.
Précillia CochardAPINOV, Research and Training Center, 10 rue Henri Bessemer, 17140, Lagord, France.ORCID http://orcid.org/0000-0001-5681-7886
Christelle SuppoInstitut de Recherche sur la Biologie de l'Insecte, UMR 7621, CNRS-Université de Tours, 37200, Tours, France.ORCID http://orcid.org/0000-0002-2277-2859
Université de Tours · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Varroa destructor is one of the greatest threats for the European honeybee, Apis mellifera. Acaricides are required to control mite infestation. Three conventional chemical acaricide substances are used in France: tau-fluvalinate, flumethrin and amitraz. Tau-fluvalinate was used for over 10 years before experiencing a loss of effectiveness. In 1995, bioassay trials showed the first mite resistance to tau-fluvalinate. In some countries, amitraz was widely used, also leading to resistance of V. destructor to amitraz. In France, some efficiency field tests showed a loss of treatment effectiveness with amitraz. We adapted the bioassay from Maggi and collaborators to determine mite susceptibility to tau-fluvalinate and amitraz in France in 2018 and 2019. The lethal concentration (LC) which kills 90% of susceptible mite strains (LC

Indexed as

AcaricidesDrug ResistanceNitrilesPyrethrinsToluidinesVarroidaeAnimalsBeesFranceAcaricidesamitrazfluvalinateNitrilesPyrethrinsToluidinesAcaricideBeekeepingHoneybeesMiteResistance

Identifiers

PMID32809187
OpenAlexW3066076458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.